Alphatec Holdings, Inc. (ATEC)
NASDAQ: ATEC · Real-Time Price · USD
9.21
-0.36 (-3.76%)
At close: Aug 6, 2026, 4:00 PM EDT
9.25
+0.04 (0.43%)
After-hours: Aug 6, 2026, 5:27 PM EDT
Alphatec Holdings Revenue
Alphatec Holdings had revenue of $213.51M in the quarter ending June 30, 2026, with 15.07% growth. This brings the company's revenue in the last twelve months to $815.05M, up 19.47% year-over-year. In the year 2025, Alphatec Holdings had annual revenue of $764.16M with 24.95% growth.
Revenue (ttm)
$815.05M
Revenue Growth
+19.47%
P/S Ratio
1.75
Revenue / Employee
$892,719
Employees
913
Market Cap
1.42B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 764.16M | 152.59M | 24.95% |
| Dec 31, 2024 | 611.56M | 129.30M | 26.81% |
| Dec 31, 2023 | 482.26M | 131.40M | 37.45% |
| Dec 31, 2022 | 350.87M | -134.60M | -27.73% |
| Dec 31, 2021 | 485.47M | 199.53M | 69.78% |
| Dec 31, 2020 | 285.94M | 172.51M | 152.09% |
| Dec 31, 2019 | 113.43M | 21.73M | 23.70% |
| Dec 31, 2018 | 91.69M | -10.05M | -9.87% |
| Dec 31, 2017 | 101.74M | -18.51M | -15.39% |
| Dec 31, 2016 | 120.25M | -14.14M | -10.52% |
| Dec 31, 2015 | 134.39M | -20.24M | -13.09% |
| Dec 31, 2014 | 154.63M | -50.10M | -24.47% |
| Dec 31, 2013 | 204.72M | 8.45M | 4.30% |
| Dec 31, 2012 | 196.28M | -1.43M | -0.72% |
| Dec 31, 2011 | 197.71M | 26.10M | 15.21% |
| Dec 31, 2010 | 171.61M | 50.99M | 42.28% |
| Dec 31, 2009 | 120.62M | 28.44M | 30.85% |
| Dec 31, 2008 | 92.18M | 12.15M | 15.18% |
| Dec 31, 2007 | 80.03M | 6.03M | 8.14% |
| Dec 31, 2006 | 74.01M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| QuidelOrtho | 2.66B |
| Enovis | 2.28B |
| Integra LifeSciences Holdings | 1.65B |
| CONMED | 1.37B |
| Tandem Diabetes Care | 1.03B |
| Inspire Medical Systems | 898.74M |
| NovoCure | 699.19M |
| Bioventus | 581.85M |
ATEC News
- 1 day ago - Alphatec price target raised to $16 from $15 at UBS - TheFly
- 1 day ago - Alphatec price target raised to $13 from $11 at TD Cowen - TheFly
- 1 day ago - Alphatec price target lowered to $19 from $23 at Canaccord - TheFly
- 1 day ago - Alphatec price target raised to $12 from $11 at BMO Capital - TheFly
- 2 days ago - Alphatec Holdings Earnings Call Transcript: Q2 2026 - Transcripts
- 2 days ago - Alphatec Holdings Slides: Q2 2026 - Filings
- 2 days ago - Alphatec Holdings Earnings release: Q2 2026 - Filings
- 2 days ago - Alphatec Holdings Quarterly report: Q2 2026 - Filings